Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics symbols : Lly save search
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
Published: 2024-04-15 (Crawled : 20:00) - globenewswire.com
CRGX | $19.1 -2.05% -1.72% 190K
|
|
| O: -1.76%
H: 6.0%
C: 2.35%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
BDTX A | $5.3 -7.02% -7.65% 1.8M
|
Health Technology
|
| O: 0.57%
H: 2.86%
C: 2.48%
AUTL | $4.8 -0.83% -0.83% 1.2M
|
Health Technology
|
| O: 0.0%
H: 2.04%
C: -0.82%
therapeutics
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Published: 2024-04-09 (Crawled : 20:00) - globenewswire.com
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
ORIC | $9.51 -2.56% -2.74% 590K
|
Health Technology
|
| O: -2.81%
H: 1.54%
C: -3.57%
NRIX 2 d | $14.44 2.56% 2.43% 1.5M
|
Health Technology
|
| O: 18.35%
H: 1.98%
C: -5.88%
therapeutics
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
MURA | $3.57 -5.05% -5.32% 240K
|
|
| O: 3.7%
H: 2.57%
C: 0.22%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.14%
H: 0.53%
C: 0.09%
medical therapeutics
Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
Published: 2024-03-26 (Crawled : 11:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.14%
H: 0.53%
C: 0.09%
expansion therapeutics
Capstan Therapeutics Announces $175M Oversubscribed Series B Financing
Published: 2024-03-20 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.35%
H: 0.4%
C: 0.36%
series therapeutics
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | News | $13.16 0.08% 0.53% 1.2M
|
Health Technology
|
| O: 0.21%
H: 0.97%
C: 0.7%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.05%
H: 0.14%
C: -0.93%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.7%
H: 0.73%
C: -0.16%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
REGN | $893.99 -0.8% -0.84% 450K
|
Health Technology
|
| O: -0.27%
H: 1.26%
C: 0.84%
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
|
| O: 0.2%
H: 1.14%
C: -1.18%
antibody therapeutics market
MOMA Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -1.3%
H: 0.61%
C: -2.37%
business therapeutics
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-27 (Crawled : 12:30) - globenewswire.com
VERV | $6.66 -1.19% -1.2% 1.2M
|
Professional, Scientific, and T...
|
| O: 5.89%
H: 15.96%
C: 14.72%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -2.2%
H: 2.39%
C: 1.34%
VRTX | News | $393.48 0.1% 0.1% 780K
|
Health Technology
|
| O: 0.15%
H: 0.66%
C: -0.74%
year pipeline therapeutics financial results
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Published: 2024-02-27 (Crawled : 12:00) - globenewswire.com
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -2.2%
H: 2.39%
C: 1.34%
ACRS | $1.23 0.4% 560K
|
Health Technology
|
| O: 2.48%
H: 10.48%
C: -3.23%
year update therapeutics financial results
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-21 (Crawled : 12:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -2.33%
H: 1.55%
C: 1.06%
UTHR | $236.93 0.69% 0.78% 480K
|
Health Technology
|
| O: 2.59%
H: 3.66%
C: -0.24%
year corporation therapeutics financial results
Animal Therapeutics and Diagnostics Global Market Report 2024 - Dermatological Disease Management in Animals to Propel Market Growth
Published: 2024-02-13 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.71%
H: 0.0%
C: 0.0%
ZTS | News | $153.11 1.05% 0.0% 4.4M
|
Health Technology
|
| O: 0.93%
H: 0.7%
C: -0.6%
TMO | News | $541.52 -1.05% -0.1% 1.8M
|
Health Technology
|
| O: 0.56%
H: 1.3%
C: 1.22%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -1.14%
H: 1.3%
C: 1.2%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.38%
H: 2.44%
C: 1.54%
ELAN | $13.57 1.19% 0.0% 3.8M
|
Process Industries
|
| O: 1.53%
H: 1.16%
C: 0.82%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: -1.14%
H: 1.3%
C: 1.2%
PAHC | $13.04 1.32% 1.45% 79K
|
Health Technology
|
| O: 1.32%
H: 4.7%
C: 4.09%
NEOG P | $11.93 -1.73% -1.68% 2.9M
|
Health Technology
|
| O: -0.24%
H: 4.39%
C: 3.29%
management propel disease report animal global animals dermatological diagnostics therapeutics growth market
Global IV & Oral Iron Drugs Market Report 2024: Market to Reach $16.43 Billion by 2029 with CSL Vifor, Covis Pharmaceuticals, Daiichi Sankyo, Akebia Therapeutics, Shield Therapeutics Dominating
Published: 2024-02-10 (Crawled : 04:20) - prnewswire.com
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
| Email alert
Add to watchlist
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
report reach global therapeutics market
Arkuda Therapeutics Announces Option and Asset Purchase Agreement
Published: 2024-02-07 (Crawled : 15:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 1.47%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.76%
H: 4.31%
C: 2.11%
therapeutics agreement
Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors
Published: 2024-02-06 (Crawled : 15:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 5.07%
H: 0.0%
C: -4.98%
health animal therapeutics
Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published: 2024-01-10 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
NVO | $122.75 -1.43% 0.65% 2.7M
|
Health Technology
|
| O: -0.33%
H: 0.35%
C: -1.5%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.67%
H: 0.85%
C: 0.21%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
ALDX | News | $3.98 0.25% 0.5% 430K
|
Health Technology
|
| O: -1.8%
H: 0.46%
C: -2.44%
companies therapeutics growth market
Nimbus Therapeutics Announces Expansion of Its Immunology Drug Discovery Pipeline
Published: 2024-01-05 (Crawled : 14:00) - biospace.com/
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.08%
H: 0.97%
C: 0.74%
drug pipeline expansion immunology therapeutics
Global Branded PAH Therapeutics Market Report 2023-2029 - Targeted Therapies Revolutionize Treatment, Growing Prevalence Spurs Market Expansion for Branded Therapeutics
Published: 2023-12-15 (Crawled : 02:00) - prnewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -4.44%
H: 0.0%
C: 0.0%
report expansion global growing therapeutics market
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
Published: 2023-12-14 (Crawled : 12:00) - globenewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: 0.0%
BEAM | $24.31 0.08% 1.7M
|
Health Technology
|
| O: 3.61%
H: 3.21%
C: 1.67%
biotech therapeutics
Allarity Therapeutics Announces Thomas Jensen as Interim CEO and Appointment of Jeremy R. Graff, PhD as Key Executive Advisor
Published: 2023-12-12 (Crawled : 11:00) - globenewswire.com
ALLR | $1.54 2.67% 11.76% 740K
|
n/a
|
| O: -2.26%
H: 9.41%
C: 7.03%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
ceo therapeutics
Global Premature Ejaculation Therapeutics Market Report 2024-2029: North America and Europe Dominate the Market in 2023, APAC Emerges as the Fastest-Growing Market
Published: 2023-12-08 (Crawled : 20:00) - prnewswire.com
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
| Email alert
Add to watchlist
america europe report global therapeutics market
Gainers vs Losers
| 60% | 40% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.